TG Therapeutics Inc (TGTX)
14.09
-0.07
(-0.49%)
USD |
NASDAQ |
Apr 15, 16:00
14.08
0.00 (0.00%)
After-Hours: 20:00
TG Therapeutics Debt to Equity Ratio: 0.6238 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.6238 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 2.415 |
| March 31, 2023 | 3.518 |
| December 31, 2022 | 1.214 |
| September 30, 2022 | 0.697 |
| June 30, 2022 | 0.5343 |
| March 31, 2022 | 0.3947 |
| December 31, 2021 | 0.2857 |
| September 30, 2021 | 0.0514 |
| June 30, 2021 | 0.0604 |
| March 31, 2021 | 0.0677 |
| December 31, 2020 | 0.0576 |
| September 30, 2020 | 0.1738 |
| June 30, 2020 | 0.1515 |
| March 31, 2020 | -21.58 |
| December 31, 2019 | 0.7502 |
| September 30, 2019 | -1.114 |
| June 30, 2019 | 2.159 |
| March 31, 2019 | 1.469 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.0013 |
| June 30, 2018 | 0.0021 |
| March 31, 2018 | 0.0026 |
| December 31, 2017 | 0.0019 |
| Date | Value |
|---|---|
| September 30, 2017 | 0.0023 |
| June 30, 2017 | 0.002 |
| March 31, 2017 | 0.0017 |
| December 31, 2016 | 0.0019 |
| September 30, 2016 | 0.0021 |
| June 30, 2016 | 0.0012 |
| March 31, 2016 | 0.0017 |
| December 31, 2015 | 0.0021 |
| September 30, 2015 | 0.0016 |
| June 30, 2015 | 0.0026 |
| March 31, 2015 | 0.0026 |
| December 31, 2014 | 0.0034 |
| September 30, 2014 | 0.0027 |
| June 30, 2014 | 0.0031 |
| March 31, 2014 | 0.0021 |
| December 31, 2013 | 0.0185 |
| September 30, 2013 | 0.066 |
| June 30, 2013 | 0.2961 |
| March 31, 2013 | 0.211 |
| December 31, 2012 | 0.203 |
| September 30, 2012 | 0.5397 |
| June 30, 2012 | 0.4605 |
| March 31, 2012 | 0.4551 |
| December 31, 2011 | 0.4335 |
| September 30, 2011 | -59.76 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-21.58
Minimum
Mar 2020
3.518
Maximum
Mar 2023
-0.5022
Average
0.2857
Median
Dec 2021
Debt to Equity Ratio Benchmarks
| Amicus Therapeutics Inc | 2.422 |
| Geron Corp | 0.3305 |
| Editas Medicine Inc | 0.00 |
| G1 Therapeutics Inc | 1.457 |
| Mersana Therapeutics Inc | 0.6837 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 329.59M |
| Total Liabilities (Quarterly) | 169.08M |
| Shareholders Equity (Quarterly) | 160.50M |
| Current Ratio | 5.918 |
| Net Debt Paydown Yield | -0.23% |